• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[重症监护病房中的白血病患者]

[The patient with leukemia in the intensive care unit].

作者信息

Zierhut S, Reichle A

机构信息

1Klinik und Poliklinik für Innere Medizin I, Universität Regensburg, 93042 Regensburg, Germany.

2Abteilung für Hämatologie und Onkologie, Universität Regensburg, 93042 Regensburg, Germany.

出版信息

Intensivmed Notfallmed. 2007;44(5):286-302. doi: 10.1007/s00390-007-0783-9. Epub 2007 May 31.

DOI:10.1007/s00390-007-0783-9
PMID:32287640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7101893/
Abstract

Patients with leukemia are prone to critical illness at some time during their disease and their therapy that requires critical care. A number of these patients will have the opportunity to receive curative treatment and have an excellent probability of long-term remission if supported through a crisis. Complications that cause critical illness can be categorized as related to disease or those caused by therapy. The present review is focused on the description of the types of complications requiring intensive care, on specific aspects of the application of critical-care techniques, on organization of the intensive care unit in the context of leukemia and on ethical considerations.

摘要

白血病患者在其疾病及治疗过程中的某些时候容易发生需要重症监护的危重症。如果在危机期间得到支持,这些患者中有许多将有机会接受根治性治疗并有很高的长期缓解概率。导致危重症的并发症可分为与疾病相关的或由治疗引起的。本综述重点描述需要重症监护的并发症类型、重症监护技术应用的具体方面、白血病背景下重症监护病房的组织以及伦理考量。

相似文献

1
[The patient with leukemia in the intensive care unit].[重症监护病房中的白血病患者]
Intensivmed Notfallmed. 2007;44(5):286-302. doi: 10.1007/s00390-007-0783-9. Epub 2007 May 31.
2
Critical care of the patient with hematologic malignancy.
AACN Clin Issues. 1996 Feb;7(1):65-78. doi: 10.1097/00044067-199602000-00006.
3
Intensive care and oncology.重症监护与肿瘤学。
Support Care Cancer. 1995 Mar;3(2):93-105. doi: 10.1007/BF00365848.
4
Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.血清血栓调节蛋白水平与脓毒症患者的弥散性血管内凝血、多器官功能障碍综合征的临床病程及死亡率相关。
Crit Care Med. 2008 Mar;36(3):683-9. doi: 10.1097/CCM.0B013E31816537D8.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.急性和慢性白血病患者弥散性血管内凝血的治疗
Cochrane Database Syst Rev. 2015 Jun 24;2015(6):CD008562. doi: 10.1002/14651858.CD008562.pub3.
7
Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.评估低剂量拉布立酶在血液恶性肿瘤危重症患儿中的安全性和疗效。
Int J Clin Pharm. 2020 Dec;42(6):1440-1446. doi: 10.1007/s11096-020-01144-8. Epub 2020 Sep 24.
8
Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit.重症监护病房中接受化疗的癌症患者的预后因素、长期生存情况及结局
Ann Hematol. 2014 Oct;93(10):1629-36. doi: 10.1007/s00277-014-2141-x. Epub 2014 Jul 6.
9
Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.活化部分凝血活酶时间波形分析在外科重症监护病房患者脓毒症及显性弥散性血管内凝血识别中的应用
Crit Care Med. 2004 Feb;32(2):520-4. doi: 10.1097/01.CCM.0000110678.52863.F3.
10
Management of hematological patients requiring emergency chemotherapy in the intensive care unit.重症监护病房中需要紧急化疗的血液学患者的管理。
Intensive Care Med. 2024 Jun;50(6):849-860. doi: 10.1007/s00134-024-07454-z. Epub 2024 May 15.

本文引用的文献

1
Antifungal prophylaxis for invasive mycoses in high risk patients.高危患者侵袭性真菌病的抗真菌预防
Curr Opin Infect Dis. 2006 Dec;19(6):571-6. doi: 10.1097/QCO.0b013e3280108e45.
2
Anthracycline cardiotoxicity.蒽环类药物心脏毒性
Expert Opin Drug Saf. 2006 Nov;5(6):791-809. doi: 10.1517/14740338.5.6.791.
3
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.中性粒细胞减少和非中性粒细胞减少患者侵袭性曲霉病的流行病学、临床和生物学特征比较:一项为期6年的调查。
Clin Infect Dis. 2006 Sep 1;43(5):577-84. doi: 10.1086/505870. Epub 2006 Jul 27.
4
Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.新诊断恶性肿瘤且需要癌症化疗患者的重症监护。
Crit Care Med. 2005 Nov;33(11):2488-93. doi: 10.1097/01.ccm.0000181728.13354.0a.
5
Prognosis of patients with acute myeloid leukaemia admitted to intensive care.入住重症监护病房的急性髓系白血病患者的预后
Br J Haematol. 2005 May;129(3):350-7. doi: 10.1111/j.1365-2141.2005.05459.x.
6
Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis.需要有创机械通气的急性髓系白血病合并肺部浸润患者的结局——一项回顾性分析
J Crit Care. 2004 Mar;19(1):29-35. doi: 10.1016/j.jcrc.2004.02.006.
7
Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients.中性粒细胞减少持续时间对中性粒细胞减少的危重症癌症患者短期死亡率的影响。
Intensive Care Med. 2002 Dec;28(12):1775-80. doi: 10.1007/s00134-002-1528-7. Epub 2002 Oct 25.
8
Prognosis of hematologic malignancies does not predict intensive care unit mortality.血液系统恶性肿瘤的预后无法预测重症监护病房的死亡率。
Crit Care Med. 2002 Oct;30(10):2260-70. doi: 10.1097/00003246-200210000-00014.
9
Mechanical ventilation in critically ill cancer patients.
Curr Opin Oncol. 2001 Jul;13(4):224-8. doi: 10.1097/00001622-200107000-00003.
10
Outcome of bone marrow transplantation patients requiring mechanical ventilation.需要机械通气的骨髓移植患者的结局
Crit Care Med. 2000 Apr;28(4):1014-7. doi: 10.1097/00003246-200004000-00017.